Warmest Wishes for 2021
As our community knows, the COVID-19 pandemic greatly affected all aspects of breast cancer care, including clinical trials. Yet, with your support, we have been...
Read MoreWhen to Use Surgery & Radiation to the Breast
Headlines announcing the phase III clinical trial (ECOG-ACRIN 2108) results stated that radiation and surgery to the breast–also called locoregional therapy...
Read MoreMetastatic Trial Search: New & Improved
Metastatic Trial Search has been re-designed and updated. We’ve provided more personalized matching by adding: New biomarkers: PD-L1, Androgen...
Read MoreBody Image and Metastatic Breast Cancer
Research shows that changes to the body caused by metastatic cancer or treatments for metastatic cancer can affect a person’s body image. Body image is how...
Read MoreIndividualized Dosing for People with MBC
Personalized medicine is not just about what medication to choose, but also about how a medication is given. One important concept is the right dose, a...
Read MoreFDA Approves Keytruda®
On November 13, 2020, the FDA approved pembrolizumab (Keytruda®) in combination with chemotherapy for the treatment of patients with locally recurrent...
Read MoreArt Therapy for People with MBC
Art therapy is a tool used for a variety of purposes, including self-expression, communication, and releasing strong emotions. Research has shown that art therapy...
Read MoreHER2-Low Expressing: A New Subcategory of HER2-Negative Breast Cancer?
Under current treatment guidelines, breast cancer is categorized as HER2-positive or HER2-negative. However, some investigators use the term HER2-low expressing...
Read MoreHow to Prepare for a Virtual SABCS
The San Antonio Breast Cancer Symposium (SABCS) is an important annual breast cancer conference. Last year, SABCS offered more than 1,700 breast cancer-related...
Read MoreSEARCH OUR SITE
for past articles or specific information.